Avanir (AVNR) More Than Doubles On NUEDEXTA Approval
Tweet Send to a Friend
Shares of Avanir Pharmaceuticals (Nasdaq: AVNR) are trading up 114 percent to $5.18 in pre-open ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


